FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Central Admixture Pharmacy Services norepinephrine Recall

norepinephrine, 16 mg, added to dextrose 5% 250 mL, IV Bag, CONCENTRATION 64 mcg/mL, Rx…

Central Admixture Pharmacy Services, Inc. · Phoenix, AZ

Risk level
Class II
Reported by FDA
Aug 9, 2023
Recall ID
D-0988-2023
Check your lot numberHow we source this data

Summary

Central Admixture Pharmacy Services recalled norepinephrine starting Jul 14, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0988-2023 on Aug 9, 2023. Reason: Lack of assurance of sterility. Validation data for decontamination cycles is lacking. Status: Terminated.

Why it was recalled

Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Product description

norepinephrine, 16 mg, added to dextrose 5% 250 mL, IV Bag, CONCENTRATION 64 mcg/mL, Rx Only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC 72196-8095-1

Lot numbers, UPCs & expiration codes

Lot: 36-257069, Exp. 9/14/2023.

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0988-2023
Classification
Class II
Status
Terminated
Recall initiated
Jul 14, 2023
FDA report date
Aug 9, 2023
Quantity
80 bags
Recall type
Voluntary: Firm initiated
Recalling firm
Central Admixture Pharmacy Services, Inc.

Original FDA data

Every field from FDA enforcement report D-0988-2023, exactly as published.

Show all FDA fields
City
Phoenix
State
AZ
Status
Terminated
Country
United States
Event ID
92707
Address
2200 S 43rd Ave
Code information
Lot: 36-257069, Exp. 9/14/2023.
Postal code
85043-3909
Report date
Aug 9, 2023
Product type
Drugs
Recall number
D-0988-2023
Classification
Class II
Recalling firm
Central Admixture Pharmacy Services, Inc.
Product quantity
80 bags
Termination date
Mar 28, 2025
Reason for recall
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Voluntary / mandated
Voluntary: Firm initiated
Product description
norepinephrine, 16 mg, added to dextrose 5% 250 mL, IV Bag, CONCENTRATION 64 mcg/mL, Rx Only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC 72196-8095-1
Distribution pattern
Nationwide in the USA
Recall initiation date
Jul 14, 2023
Initial firm notification
Letter
Center classification date
Aug 1, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0988-2023, published Aug 9, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls